Activity of imipenem against multiresistant gram-negative bacilli isolated from Riyadh hospitals

Saudi Medical Journal

Volumn 17, Issue 3, 1996, Pages 322-326

  Shibl, Atef M ^a,c   Tawfik, Abdel Kader F ^b   Ramadan, Mohammed A ^a   Al Zamel, Fatten A ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

imipenem; killing capacity; multiresistant gram negative bacilli

Indexed keywords

AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; IMIPENEM;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HOSPITAL; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SAUDI ARABIA; SERRATIA MARCESCENS;

EID: 0029739267     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Piddock LIV. Traynor EA, Wise RA. Comparison of the mechanisms of decreased susceptibility of aztreonamresistant and ceftazidime-resistant Enterobacteriacae. J Antimicrob Chem 1990; 26: 749-762.
2. Wideman B, Tolxdorff-Neutzling RM. Mechanism of resistance to beta-lactam antibiotics. Chemotherapia 1985; 4: 24-27.
3. Shibl AM. Trends in microbial resistance to antibiotics. Saudi Pharmaceutical J. 1994; 2: 183-188.
4. National Committee for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Third Ed. 1993: M7 A3. NCCLS, Villanova, Pa.
5. Legrand P, Fourneir G, Bure A, Jarlier V, Nicholoas MH et al. Detection of extended broad spectrum beta-lactamases in Enterobacteriaceae in four French hospitals. Eur J Clin Microbiol & Infect Dis 1989; 8: 527-529.
6. Bakken JS, Sanders CC, Thomson KS. Selective ceftazidime resistance in Escherichia coli: association with changes in outer membrane protein. J Infect Dis 1987; 155: 1220-1225.
7. Sanders CC, Sanders Jr WE. Clinical importance of inducible beta-lactamses in gram-negative bacteria. Eur J Clin Microbiol 1987; 6: 435-437.
8. Pechere JC. Why carbapenem are active against Enterobacter cloacae resistant to third generation cephalosporins. Scand J Infect Dis 1991; 78(Suppl.): 17-21.
9. Arlet G, Rouveau M, Fournier G, Lagrange PH, Philippon A. Novel plasmid beta-Jactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephaiosporins. Antimicrob Agents Chemother 1993; 37: 2020-2026.
10. Neu HC, Gu JW, Fang W, Chin NX. In vitro activity and beta-lactamase stability of LJC 10,627. Antimicrob Agents Chemother 1992; 36: 1418-1423.
11. Zemmelman R. Bello H. Dominguez M, Gonzalez G, Mella S, Garcia A. Activity of imipenem, third generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated for Chilean hospitals. J Antimicrob Chemother 1993; 32: 413-419.
12. Tausk, F, Evans ME, Patterson LS, Federspiel CF, Stratton CW. Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1985; 28: 41-45.
13. Trias J, Nikaido H. Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1990; 34: 52-57.
14. Goldstein FW, Gutmann L, Williamson R, Collatz E, Acar JF. In vivo and in vitro emergence of simultaneous resistance to beta-lactam and aminoglycoside antibiotics in Serratia marcescens. Annal de Microbiologie (Paris) 1983; 134: 329-357.